<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">
<channel>
<title>Head &amp; Neck Cancer – DOI-Enriched Feed</title>
<link>https://colmmemedsurv.github.io/sentinelnode/</link>
<description>Curated head &amp; neck cancer literature with PubMed enrichment.</description>
<lastBuildDate>Mon, 22 Dec 2025 02:02:19 -0000</lastBuildDate>
<item>
<title>ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMoa2511885?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMoa2511885?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Noninferiority of One HPV Vaccine Dose to Two Doses</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMoa2506765?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMoa2506765?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Evidence to Action — Single-Dose HPV Vaccination and Cervical HPV Infection</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMe2515387?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMe2515387?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Reducing Tobacco Use Worldwide: The Epidemic of Tobacco Harms among People with Mental Health Conditions</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMp2500491?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMp2500491?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Merkel-Cell Carcinoma</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMicm2513302?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMicm2513302?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>ctDNA-Guided Therapy in Bladder Cancer — Ready?</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMe2514185?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMe2514185?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMoa2511648?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMoa2511648?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Understanding How Aspirin Prevents Metastasis</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMcibr2502386?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMcibr2502386?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Disitamab Vedotin plus Toripalimab — New Players in Urothelial Carcinoma</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMe2514668?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMe2514668?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Molecular Evidence of Multiorgan Damage in Patients with Immune-Related Adverse Events</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMc2513984?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMc2513984?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMoa2514661?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMoa2514661?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Ianalumab plus Eltrombopag in Immune Thrombocytopenia</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMoa2515168?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMoa2515168?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMoa2514663?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMoa2514663?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMoa2505478?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMoa2505478?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMoa2514332?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMoa2514332?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMoa2514752?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMoa2514752?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Brief Report: Prime Editing for p47phox-Deficient Chronic Granulomatous Disease</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMoa2509807?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMoa2509807?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMoa2515458?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMoa2515458?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Engasertib versus Placebo for Bleeding in Hereditary Hemorrhagic Telangiectasia</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMoa2504411?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMoa2504411?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Case 34-2025: A 57-Year-Old Woman with Visual Disturbances and Right-Arm Shaking</title>
<link>https://www.nejm.org/doi/full/10.1056/NEJMcpc2513534?rss=searchAndBrowse</link>
<guid isPermaLink='true'>https://www.nejm.org/doi/full/10.1056/NEJMcpc2513534?rss=searchAndBrowse</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Editorial] Making prostate cancer screening fit for purpose</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00672-2/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00672-2/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] Defining eligibility for lung cancer screening based on individual risk</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00537-6/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00537-6/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] Pirfenidone: a new option for radiation-induced lung injury?</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00544-3/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00544-3/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom?</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00621-7/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00621-7/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] Of surrogate endpoints, shortcuts, and safety</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00663-1/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00663-1/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] Evolution in rectal cancer management</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00600-X/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00600-X/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] Increased extent of neurosurgical resection in IDH-mutated glioma: issues for translation to standard practice</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00592-3/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00592-3/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] Focused ultrasound treatments could increase survival in individuals with glioma</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00552-2/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00552-2/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] Targeting IDH mutation: another milestone, but not the finish line</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00491-7/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00491-7/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] Re-establishing human-centred care</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00604-7/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00604-7/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] A deliverable national cancer control plan for the UK: lessons from abroad and the need for discipline at home</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00650-3/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00650-3/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] The paradox of generics: broader access, less freedom</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00613-8/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00613-8/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Correspondence] SunRISe-4 perioperative safety and TURBT stratification</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00553-4/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00553-4/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Correspondence] SunRISe-4 perioperative safety and TURBT stratification – Authors&#x27; reply</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00671-0/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00671-0/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Correspondence] SBRT in oligometastatic castration-resistant prostate cancer</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00565-0/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00565-0/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Correspondence] Misclassification of p16-positive, HPV-negative patients biases de-escalation trials</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00616-3/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00616-3/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Correspondence] Misclassification of p16-positive, HPV-negative patients biases de-escalation trials – Authors&#x27; reply</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00655-2/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00655-2/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Corrections] Correction to Lancet Oncol 2024; 25: 1038–52</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00522-4/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00522-4/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Corrections] Correction to Lancet Oncol 2025; 26: 1443–53</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00668-0/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00668-0/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[News] ESMO Congress 2025</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00644-8/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00644-8/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[News] Eastern Mediterranean Region backs Cairo Call on breast cancer</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00645-X/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00645-X/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[News] New Zealand extends breast cancer screening to 70–74-year-olds</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00646-1/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00646-1/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[News] Europe&#x27;s Beating Cancer Plan delayed by “legislative inaction”</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00657-6/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00657-6/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[News] More e-cigarette users than cigarette smokers for the first time in the UK</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00676-X/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00676-X/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[News] Government shutdown and Medicare changes impact cancer care in the USA</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00677-1/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00677-1/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Perspectives] Cancer and comedy: a review of three stand-up specials</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00673-4/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00673-4/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Perspectives] Cancer revolution: science, innovation, and hope</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00674-6/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00674-6/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Perspectives] Humour in the face of hardship</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00675-8/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00675-8/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Perspectives] When healing means letting go</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00659-X/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00659-X/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Effectiveness of NELSON versus PLCOm2012 lung cancer screening eligibility criteria in Germany (HANSE): a prospective cohort study</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00490-5/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00490-5/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00515-7/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00515-7/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00523-6/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00523-6/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00545-5/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00545-5/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00546-7/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00546-7/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00543-1/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00543-1/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Total neoadjuvant therapy followed by non-operative management or surgery in stage II–III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00542-X/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00542-X/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trial</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00605-9/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00605-9/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00534-0/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00534-0/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00492-9/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00492-9/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00472-3/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00472-3/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 study</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00514-5/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00514-5/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[The Lancet Oncology Commission] The human crisis in cancer: a Lancet Oncology Commission</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00530-3/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00530-3/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Review] Neurocognitive outcomes in patients with brain metastases: a systematic review</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00525-X/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00525-X/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Policy Review] SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00520-0/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00520-0/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Policy Review] The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer—a multidisciplinary consensus</title>
<link>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00463-2/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00463-2/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet Oncology</prism:publicationName>
<description>Journal: The Lancet Oncology</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet Oncology</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Editorial] 2025: an annus horribilis for health in the USA</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02588-7/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02588-7/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] Oral small-molecule GLP-1 receptor agonist for type 2 diabetes and obesity</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02381-5/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02381-5/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] Neoadjuvant quadruplet chemotherapy PAXG for pancreatic cancer</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01864-1/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01864-1/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] Methoxyflurane: a promising non-intravenous, non-opioid analgesic</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01532-6/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01532-6/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] Exploring CAR NK-cell therapy for refractory lupus</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01949-X/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01949-X/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] US CDC: a public health agency in critical condition</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02353-0/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02353-0/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] The 2025 Wakley Prize: finding a home in medicine</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02553-X/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02553-X/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Comment] Offline: Watching the watchers (part 3)</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02516-4/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02516-4/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[World Report] Grants under threat at the US National Institutes of Health</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02590-5/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02590-5/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[World Report] UN Environmental Assembly passes AMR resolution</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02591-7/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02591-7/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[World Report] Southeast Asia reels after tropical storms</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02592-9/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02592-9/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Perspectives] Highlights 2025: illuminating health stories</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02550-4/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02550-4/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Correspondence] Darfur&#x27;s humanitarian emergency: a call for immediate action</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02383-9/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02383-9/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Correspondence] Gender-based violence and displacement in Darfur&#x27;s war</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02384-0/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02384-0/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Correspondence] Russia&#x27;s health workers complicit in abducting Ukraine&#x27;s children</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02388-8/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02388-8/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Correspondence] Cerebral palsy: an update on its early detection</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02310-4/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02310-4/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Correspondence] Cerebral palsy: an update on its early detection – Authors&#x27; reply</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02311-6/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02311-6/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Correspondence] The need for metabolic health stratification in global obesity forecasts</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01234-6/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01234-6/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Correspondence] The need for metabolic health stratification in global obesity forecasts – Authors&#x27; reply</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02312-8/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02312-8/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Correspondence] The diabetic foot after SWHSI-2: healing is not one size fits all</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02070-7/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02070-7/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Correspondence] The diabetic foot after SWHSI-2: healing is not one size fits all – Authors&#x27; reply</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02247-0/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02247-0/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Department of Error] Department of Error</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02551-6/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02551-6/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02165-8/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02165-8/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01685-X/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01685-X/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Comparison of inhalational methoxyflurane, intranasal fentanyl, and intravenous morphine for treatment of prehospital acute pain in Norway (PreMeFen): a randomised, non-inferiority, three-arm, phase 3 trial</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01575-2/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01575-2/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Articles] Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01671-X/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01671-X/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Hypothesis] Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01776-3/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01776-3/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Lecture] Lessons from Africa: health diplomacy in HIV prevention</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01976-2/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01976-2/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>[Wakley Prize essay] Home</title>
<link>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02467-5/fulltext?rss=yes</link>
<guid isPermaLink='true'>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02467-5/fulltext?rss=yes</guid>
<prism:publicationName>The Lancet</prism:publicationName>
<description>Journal: The Lancet</description>
<content:encoded><![CDATA[
<p><strong>Journal</strong>: The Lancet</p>
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Development of a simplified scoring system for MRI-detected retropharyngeal lymph node features to optimize AJCC 9th edition N classification in nasopharyngeal carcinoma</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006542?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006542?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Jaw-in-a-day (JIAD) for malignant indications: A systematic review</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006529?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006529?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Trans-hairline robotic neck dissection and robotic microvascular free flap reconstruction in oral cavity cancer</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006487?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006487?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Letter to the editor: Stroke risk after head and neck cancer diagnosis and treatment in a Real-World clinical cohort</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525005342?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525005342?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Methodological considerations in profiling the immune microenvironment and HPV status of oral multiple primary cancers</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006517?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006517?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Refining surveillance in surgically treated HPV(+)OPSCC: The path to Risk-Adapted strategies</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006414?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006414?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>The diagnostic trade-off in post-treatment surveillance for HPV-positive oropharyngeal carcinoma</title>
<link>https://www.sciencedirect.com/science/article/pii/S136883752500627X?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S136883752500627X?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Intrathyroid thymic carcinoma diagnosed following an odontogenic infection: Insights from a rare clinical presentation</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006268?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006268?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Influencing factors on occurrence and prognosis of oral squamous cell carcinoma after organ transplantation</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006530?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006530?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Treatment and outcome for 2,111 patients with vermilion lip squamous cell carcinoma: A nationwide, population-based study from the SweHNCR</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006475?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006475?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Is 55 years an optimal age cutoff point for clinical staging in T1 papillary thyroid cancer?</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006463?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006463?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>A pilot study of a digital workflow for navigated tumor bed marking to reduce clinical target volume during adjuvant radiotherapy for oral squamous cell carcinoma</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006499?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006499?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Patient-derived 3D organoid platform for functional assessment of GPC3-targeted CAR T cell cytotoxic activity in head and neck squamous cell carcinoma</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006438?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006438?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>&lt;em&gt;NOTCH1&lt;/em&gt; loss promotes chemo and radio-resistance in head and neck cancer</title>
<link>https://www.sciencedirect.com/science/article/pii/S136883752500644X?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S136883752500644X?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Integrated geriatric assessment and intervention in the head and neck oncology care pathway reduces adverse events and does not affect survival</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006402?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006402?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Neoadjuvant tislelizumab plus chemotherapy in locally advanced oral and oropharyngeal squamous cell carcinoma: A single-arm phase II clinical trial</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006384?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006384?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Blinded comparative evaluation of GPT-generated, online search-derived, and guideline-based answers for HPV-associated oropharyngeal cancer</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006426?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006426?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Incidence of HPV-independent second primary malignancies following treatment of HPV-associated malignancy</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006190?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006190?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Establishment and characterization of a new immortalized human oral keratinocyte (HOK) cell line harboring various &lt;em&gt;TP53&lt;/em&gt; mutations</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006281?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006281?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Hpv-driven rewiring of the tumor immune microenvironment through single-cell profiling informs prognosis and therapy in HNSCC</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006189?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006189?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Patterns of metastasis and nodal disease in tongue and buccal carcinomas: Case-based reflections in Delhi NCR Region</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006451?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006451?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Cerebrovascular events after head and neck radiation therapy: A systematic review and Meta-Analysis</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006396?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006396?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
<item>
<title>Survival rates and oncologic outcomes of adeno squamous carcinoma of oral cavity: A systematic review</title>
<link>https://www.sciencedirect.com/science/article/pii/S1368837525006505?dgcid=rss_sd_all</link>
<guid isPermaLink='true'>https://www.sciencedirect.com/science/article/pii/S1368837525006505?dgcid=rss_sd_all</guid>
<description>Journal: </description>
<content:encoded><![CDATA[
<hr/>
<p><strong>Abstract</strong></p>
<p>Abstract not available</p>
]]></content:encoded>
</item>
</channel></rss>
